Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Studies of Indole Based Thiadiazole Derivatives as Dual Inhibitor of Acetylcholinesterase and Butyrylchloinesterase
Document Type
Article
Publication Date
11-1-2022
Abstract
The current study was conducted to obtain hybrid analogues of indole-based thiadiazole derivatives (1–16) in which a number of reaction steps were involved. To examine their biological activity in the presence of the reference drug Donepezil (0.21 ± 0.12 and 0.30 ± 0.32 M, respectively), the inhibitory potentials of AChE and BuChE were determined for these compounds. Different substituted derivatives showing a varied range of inhibitory profiles, when compared to the reference drug, analogue 8 was shown to have potent activity, with IC50 values for AchE 0.15 ± 0.050 M and BuChE 0.20 ± 0.10, respectively, while other substituted compounds displayed good to moderate potentials. Varied spectroscopic techniques including 1H, 13CNMR and HREI-MS were used to identify the basic skeleton of these compounds. Furthermore, all analogues have a known structure–activity relationship (SAR), and molecular docking investigations have verified the binding interactions of molecule to the active site of enzymes.
Publication Title
Molecules
DOI
10.3390/molecules27217368
Recommended Citation
Khan, Shoaib; Iqbal, Shahid; Taha, Muhammad; Rahim, Fazal; Shah, Mazloom; Ullah, Hayat; Bahadur, Ali; Alrbyawi, Hamad; Dera, Ayed A.; Alahmdi, Mohammed Issa; Pashameah, Rami Adel; Alzahrani, Eman; and Farouk, Abd Elaziem, "Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Studies of Indole Based Thiadiazole Derivatives as Dual Inhibitor of Acetylcholinesterase and Butyrylchloinesterase" (2022). Kean Publications. 512.
https://digitalcommons.kean.edu/keanpublications/512